CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4 Grant or award Chief Commercial Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 200,000 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Financial Officer bought 7,760 shares at $2.17 ($16,839)
- 4 Open-market buy General Counsel and Secretary bought 9,090 shares at $2.20 ($19,998)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Commercial Officer bought 4,000 shares at an average $2.24 ($8,950)
- 4 Open-market sale Chief Executive Officer sold 122,500 shares at $3.26 ($399,350)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 9,138,504 shares at $0.23 ($2,101,856)
Page 16 of 41 · 802 filings